Application
Western blot analysis of GPSN2 Antibody (C-term) in A2058 cell line lysates (35ug/lane). GPSN2 (arrow) was detected using the purified Pab.Application
GPSN2 Antibody (C-term) IHC analysis in formalin fixed and paraffin embedded skeletal muscle followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the GPSN2 Antibody (C-term) for immunohis??| Product Name | GPSN2 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | TECR; GPSN2; SC2; Trans-2, 3-enoyl-CoA reductase; Synaptic glycoprotein SC2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | GPSN2 SC2 |
|---|---|
| Alternative Names | TECR GPSN2 SC2 Trans-2 3-enoyl-CoA reductase Synaptic glycoprotein SC2 |
| Molecular Weight(MW) | 36034 Da |
| Function | Reduces trans-2,3-stearoyl-CoA to stearoyl-CoA of long and very long chain fatty acids |
| Tissue Specificity | Expressed in most tissues tested. Highly expressed in skeletal muscle |
| Cellular Localization | Endoplasmic reticulum membrane; Multi-pass membrane protein |
| Entrez Gene | 9524 |
|---|
Application
Western blot analysis of GPSN2 Antibody (C-term) in A2058 cell line lysates (35ug/lane). GPSN2 (arrow) was detected using the purified Pab.
Application
GPSN2 Antibody (C-term) IHC analysis in formalin fixed and paraffin embedded skeletal muscle followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the GPSN2 Antibody (C-term) for immunohis??| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
